Katja Kannisto

1.4k total citations
16 papers, 1.1k citations indexed

About

Katja Kannisto is a scholar working on Molecular Biology, Physiology and Emergency Medicine. According to data from OpenAlex, Katja Kannisto has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 5 papers in Emergency Medicine. Recurrent topics in Katja Kannisto's work include Peroxisome Proliferator-Activated Receptors (8 papers), Adipose Tissue and Metabolism (8 papers) and HIV-related health complications and treatments (5 papers). Katja Kannisto is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Adipose Tissue and Metabolism (8 papers) and HIV-related health complications and treatments (5 papers). Katja Kannisto collaborates with scholars based in Sweden, Finland and United Kingdom. Katja Kannisto's co-authors include Anders Hamsten, Ewa Ehrenborg, Hannele Yki‐Järvinen, Juleen R. Zierath, Josefin Skogsberg, Per Eriksson, Elena Korsheninnikova, Lubna Al‐Khalili, Rachel M. Fisher and Anna Krook and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Virology.

In The Last Decade

Katja Kannisto

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Kannisto Sweden 16 552 468 262 239 174 16 1.1k
Julieta Díaz-Delfín Spain 12 501 0.9× 387 0.8× 60 0.2× 301 1.3× 148 0.9× 15 1.1k
Jean M. Dostou United States 11 459 0.8× 353 0.8× 454 1.7× 88 0.4× 109 0.6× 12 1.2k
Jean‐Claude Mamputu Canada 18 209 0.4× 153 0.3× 388 1.5× 189 0.8× 170 1.0× 31 1.0k
Michael Christopher Australia 12 459 0.8× 393 0.8× 434 1.7× 153 0.6× 34 0.2× 32 1.1k
J Digby United Kingdom 6 421 0.8× 560 1.2× 127 0.5× 459 1.9× 31 0.2× 11 980
C P Sewter United Kingdom 7 492 0.9× 648 1.4× 140 0.5× 515 2.2× 32 0.2× 8 1.1k
Camella G. Wilson United States 8 214 0.4× 117 0.3× 180 0.7× 279 1.2× 50 0.3× 9 598
Surinder Cheema‐Dhadli Canada 20 438 0.8× 276 0.6× 117 0.4× 78 0.3× 40 0.2× 66 1.0k
Pilar Yubero Spain 11 323 0.6× 471 1.0× 47 0.2× 204 0.9× 35 0.2× 15 675
Cynthia E. Seidman United States 9 200 0.4× 354 0.8× 394 1.5× 353 1.5× 20 0.1× 9 1.1k

Countries citing papers authored by Katja Kannisto

Since Specialization
Citations

This map shows the geographic impact of Katja Kannisto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Kannisto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Kannisto more than expected).

Fields of papers citing papers by Katja Kannisto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Kannisto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Kannisto. The network helps show where Katja Kannisto may publish in the future.

Co-authorship network of co-authors of Katja Kannisto

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Kannisto. A scholar is included among the top collaborators of Katja Kannisto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Kannisto. Katja Kannisto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sevastianova, Ksenia, Jussi Sutinen, Katja Kannisto, et al.. (2008). Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism. 295(1). E85–E91. 47 indexed citations
2.
Gredmark, Sara, et al.. (2007). Human Cytomegalovirus Downregulates Expression of Receptors for Platelet-Derived Growth Factor by Smooth Muscle Cells. Journal of Virology. 81(10). 5112–5120. 17 indexed citations
3.
Kannisto, Katja, Alexander Chibalin, Björn Glinghammar, et al.. (2006). Differential expression of peroxisomal proliferator activated receptors α and δ in skeletal muscle in response to changes in diet and exercise. International Journal of Molecular Medicine. 17(1). 45–52. 30 indexed citations
4.
Kolak, Maria, Hannele Yki‐Järvinen, Katja Kannisto, et al.. (2006). Effects of Chronic Rosiglitazone Therapy on Gene Expression in Human Adipose Tissuein Vivoin Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 92(2). 720–724. 71 indexed citations
5.
Pietiläinen, Kirsi H., Katja Kannisto, Elena Korsheninnikova, et al.. (2006). Acquired Obesity Increases CD68 and Tumor Necrosis Factor-α and Decreases Adiponectin Gene Expression in Adipose Tissue: A Study in Monozygotic Twins. The Journal of Clinical Endocrinology & Metabolism. 91(7). 2776–2781. 59 indexed citations
7.
Westerbacka, Jukka, A. H. Corner, Katja Kannisto, et al.. (2005). Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia. 49(1). 132–140. 47 indexed citations
8.
Kramer, David, Lubna Al‐Khalili, Sebastio Perrini, et al.. (2005). Direct Activation of Glucose Transport in Primary Human Myotubes After Activation of Peroxisome Proliferator–Activated Receptor δ. Diabetes. 54(4). 1157–1163. 113 indexed citations
9.
Kannisto, Katja, Kirsi H. Pietiläinen, Ewa Ehrenborg, et al.. (2004). Overexpression of 11β-Hydroxysteroid Dehydrogenase-1 in Adipose Tissue Is Associated with Acquired Obesity and Features of Insulin Resistance: Studies in Young Adult Monozygotic Twins. The Journal of Clinical Endocrinology & Metabolism. 89(9). 4414–4421. 172 indexed citations
10.
Sutinen, Jussi, Katja Kannisto, Elena Korsheninnikova, et al.. (2004). Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism. 286(6). E941–E949. 45 indexed citations
13.
Al‐Khalili, Lubna, Alexander Chibalin, Katja Kannisto, et al.. (2003). Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cellular and Molecular Life Sciences. 60(5). 991–998. 106 indexed citations
14.
Skogsberg, Josefin, Katja Kannisto, Tobias N. Cassel, et al.. (2003). Evidence That Peroxisome Proliferator–Activated Receptor Delta Influences Cholesterol Metabolism in Men. Arteriosclerosis Thrombosis and Vascular Biology. 23(4). 637–643. 114 indexed citations
15.
Yki‐Järvinen, Hannele, Jussi Sutinen, Angela Silveira, et al.. (2003). Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone Therapy. Arteriosclerosis Thrombosis and Vascular Biology. 23(4). 688–694. 53 indexed citations
16.
Skogsberg, Josefin, et al.. (2000). Characterization of the human peroxisome proliferator activated receptor delta gene and its expression.. International Journal of Molecular Medicine. 6(1). 73–81. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026